We provide liquidity to eliminate friction and accelerate growth.

Select a focus below

Flexible Capital for Healthcare Companies

How we help

We invest in rapidly growing healthcare companies and actively partner with management teams to help them scale their business.

We create customized solutions that provide liquidity and align shareholders. Building an enduring business takes time, and we recognize that not all stakeholders have the same time horizon. Our flexible, long-term approach allows us to address the issues faced by a wide range of counterparties.

Our typical investment size is $5 to $50 million. We have participated in deals as large as $1 billion.

Flexible Capital Solutions:

  • Growth Capital
  • Shareholder Liquidity
  • Founder Liquidity
  • Early Employee or Angel Investor Liquidity
  • Venture and Private Equity Fund Liquidity
  • Corporate Investor Liquidity

VitalConnect

VitalConnect is a leader in wearable biosensor technology for wireless patient monitoring in both remote patient populations and hospitals.

Revelation Partners has been an ongoing strategic partner, providing liquidity to existing shareholders as well as growth capital:

  • Acquired preferred shares from an early-stage venture fund
  • Structured and led a $30 million Series F financing round
Read More

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. 

“This latest round of financing, at an increased valuation, signals unwavering support from our investors while providing the company the runway needed to achieve our goal of being the world’s leading provider of remote patient monitoring solutions.”

– Peter Van Haur, CEO of VitalConnect

Iris Telehealth

Iris Telehealth is a leading telepsychiatry company with a platform treating medium to high acuity patients, ensuring access to the best mental health specialists and prescribers. Iris serves the continuum of inpatient setting across the U.S.:

  • Community mental health centers
  • Community health centers
  • Health systems
  • Hospitals

Revelation Partners acquired common shares from early employees who sought personal liquidity.
Read More

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. 

“Iris is a nationally recognized leader in the telepsychiatry space. We are excited to partner with Tarik, Andy, and the rest of the exceptional management team.”

– Fred Lee, Partner

Metabolon

Metabolon, Inc. is the global leader in providing metabolomics solutions that advance a wide variety of research, diagnostic, therapeutic development, and precision medicine applications.

Revelation Partners has been an ongoing strategic capital partner for Metabolon:

  • Provided liquidity to a mix of early preferred and common shareholders
  • Invested in Metabolon’s $25 million primary financing to accelerate commercialization activities and continue advancing its well-defined R&D roadmap
Read More

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. 

“We are very excited to support the leader in Metabolomics services as they make this technology the standard for multi-omics analysis. They have assembled an excellent team, with CEO Rohan Hastie and CFO Gerry Haines, who are changing this field and making Metabolon the standard for this work.”

– Doug Fisher, Partner

We tailor solutions to fit the specific needs of a company and its investors.

We pride ourselves in responsiveness, problem-solving, and delivering results.

When we make an investment, we’re dedicated to being an ongoing strategic partner to help navigate growth and align shareholders.

FAQ

What type of companies does Revelation Partners seek to invest in?

We invest in late-stage, private companies across healthcare sectors, including medical devices, biopharmaceuticals, healthcare technology and services, and life science tools and diagnostics. If commercial scale, companies typically have at least $20 million of revenue. When value is driven by clinical progress, companies will have a validated technology.

What type of shares is Revelation Partners willing to acquire?

We can acquire all classes of shares. Depending on the dynamics of the transaction, we can also acquire limited partnership interests, partner with the GP, or indirectly acquire an interest through a structured transaction.

What type of counterparty does Revelation Partners typically transact with?

We have a long history of transacting with a wide range of counterparties, from companies raising growth capital, to founders, venture and private equity funds, corporate investors, early employees, and angel investors seeking liquidity.

Shareholder Liquidity

How we help

Revelation Partners creates customized solutions which provide liquidity and align shareholders of privately-held healthcare companies. Building an enduring business takes time, and not all investors – or founders – have the same time horizon.

We provide liquidity for both common and preferred classes of shares and transact with a wide range of counterparties.

Our typical investment size is $5 to $50 million. We have participated in deals as large as $1 billion.

Liquidity Solutions:

  • Founder Liquidity
  • Early Employee or Angel Investor Liquidity
  • Venture and Private Equity Fund Liquidity
  • Corporate Investor Liquidity

GE Ventures

Revelation Partners purchased a portfolio of 15 private healthcare investments from GE Ventures.

The transaction delivered a comprehensive solution:

  • Immediate liquidity for 15 assets
  • Reserves for future follow-on financings
  • A committed and ongoing partner for underlying companies, including BOD roles
  • Maintained strategic relationship between GE and select companies
Read More

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. 

“This decision was made with [the companies’] growth in mind, given Revelation Partners’ expertise. We look forward to watching these companies continue to grow and flourish.”

– David Mayhew, Chief Investment Officer of GE Ventures

VitalConnect

VitalConnect is a leader in wearable biosensor technology for wireless patient monitoring in both remote patient populations and hospitals.

Revelation Partners has been an ongoing strategic partner, providing liquidity to existing shareholders as well as growth capital:

  • Acquired preferred shares from an early-stage venture fund
  • Structured and led a $30 million Series F financing round
Read More

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. 

“This latest round of financing, at an increased valuation, signals unwavering support from our investors while providing the company the runway needed to achieve our goal of being the world’s leading provider of remote patient monitoring solutions.”

– Peter Van Haur, CEO of VitalConnect

Iris Telehealth

Iris Telehealth is a leading telepsychiatry company with a platform treating medium to high acuity patients, ensuring access to the best mental health specialists and prescribers. Iris serves the continuum of inpatient setting across the U.S.:

  • Community mental health centers
  • Community health centers
  • Health systems
  • Hospitals

Revelation Partners acquired common shares from early employees who sought personal liquidity.
Read More

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. 

“Iris is a nationally recognized leader in the telepsychiatry space. We are excited to partner with Tarik, Andy, and the rest of the exceptional management team.”

– Fred Lee, Partner

Metabolon

Metabolon, Inc. is the global leader in providing metabolomics solutions that advance a wide variety of research, diagnostic, therapeutic development, and precision medicine applications.

Revelation Partners has been an ongoing strategic capital partner for Metabolon:

  • Provided liquidity to a mix of early preferred and common shareholders
  • Invested in Metabolon’s $25 million primary financing to accelerate commercialization activities and continue advancing its well-defined R&D roadmap
Read More

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. 

“We are very excited to support the leader in Metabolomics services as they make this technology the standard for multi-omics analysis. They have assembled an excellent team, with CEO Rohan Hastie and CFO Gerry Haines, who are changing this field and making Metabolon the standard for this work.”

– Doug Fisher, Partner

We tailor solutions to fit the specific needs of a company and its investors.

We pride ourselves in responsiveness, problem-solving, and delivering results. 

When we make an investment, we’re dedicated to being an ongoing strategic partner to help navigate growth and align shareholders.

FAQ

What type of companies does Revelation Partners seek to invest in?

We invest in late-stage, private companies across healthcare sectors, including medical devices, biopharmaceuticals, healthcare technology and services, and life science tools and diagnostics. If commercial scale, companies typically have at least $20 million of revenue. When value is driven by clinical progress, companies will have a validated technology.

What type of shares is Revelation Partners willing to acquire?

We can acquire all classes of shares. Depending on the dynamics of the transaction, we can also acquire limited partnership interests, partner with the GP, or indirectly acquire an interest through a structured transaction.

What type of counterparty does Revelation Partners typically transact with?

We have a long history of transacting with a wide range of counterparties, from companies raising growth capital, to founders, venture and private equity funds, corporate investors, early employees, and angel investors seeking liquidity.

Fund Manager Solutions

How we help

Revelation Partners creates customized solutions which provide liquidity and align shareholders of privately-held healthcare companies. Building an enduring business takes time, and not all investors – or founders – have the same time horizon.

Fund managers often find themselves facing limited capital reserves, fund end-of-life issues, and demands for liquidity from their limited partners.

Our typical investment size is $5 to $50 million. We have participated in deals as large as $1 billion.

Fund Manager Solutions:

  • Direct Liquidity
  • Follow-On Capital
  • Multi and Single Asset Continuation Funds
  • Fund Restructurings
  • LP Tenders

GE Ventures

Revelation Partners purchased a portfolio of 15 private healthcare investments from GE Ventures.

The transaction delivered a comprehensive solution:

  • Immediate liquidity for 15 assets
  • Reserves for future follow-on financings
  • A committed and ongoing partner for underlying companies, including BOD roles
  • Maintained strategic relationship between GE and select companies
Read More

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. 

“This decision was made with [the companies’] growth in mind, given Revelation Partners’ expertise. We look forward to watching these companies continue to grow and flourish.”

– David Mayhew, Chief Investment Officer of GE Ventures

VitalConnect

VitalConnect is a leader in wearable biosensor technology for wireless patient monitoring in both remote patient populations and hospitals.

Revelation Partners has been an ongoing strategic partner, providing liquidity to existing shareholders as well as growth capital:

  • Acquired preferred shares from an early-stage venture fund
  • Structured and led a $30 million Series F financing round
Read More

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. 

“This latest round of financing, at an increased valuation, signals unwavering support from our investors while providing the company the runway needed to achieve our goal of being the world’s leading provider of remote patient monitoring solutions.”

– Peter Van Haur, CEO of VitalConnect

Metabolon

Metabolon, Inc. is the global leader in providing metabolomics solutions that advance a wide variety of research, diagnostic, therapeutic development, and precision medicine applications.

Revelation Partners has been an ongoing strategic capital partner for Metabolon:

  • Provided liquidity to a mix of early preferred and common shareholders
  • Invested in Metabolon’s $25 million primary financing to accelerate commercialization activities and continue advancing its well-defined R&D roadmap
Read More

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. 

“We are very excited to support the leader in Metabolomics services as they make this technology the standard for multi-omics analysis. They have assembled an excellent team, with CEO Rohan Hastie and CFO Gerry Haines, who are changing this field and making Metabolon the standard for this work.”

– Doug Fisher, Partner

We tailor solutions to fit the specific needs of a company and its investors.

We pride ourselves in responsiveness, problem-solving, and delivering results.

When we make an investment, we’re dedicated to being an ongoing strategic partner to help navigate growth and align shareholders.

FAQ

What type of companies does Revelation Partners seek to invest in?

We invest in late-stage, private companies across healthcare sectors, including medical devices, biopharmaceuticals, healthcare technology and services, and life science tools and diagnostics. If commercial scale, companies typically have at least $20 million of revenue. When value is driven by clinical progress, companies will have a validated technology.

What type of shares is Revelation Partners willing to acquire?

We can acquire all classes of shares. Depending on the dynamics of the transaction, we can also acquire limited partnership interests, partner with the GP, or indirectly acquire an interest through a structured transaction.

What type of counterparty does Revelation Partners typically transact with?

We have a long history of transacting with a wide range of counterparties, from companies raising growth capital, to founders, venture and private equity funds, corporate investors, early employees, and angel investors seeking liquidity.

“Often shareholders become misaligned over time and this misalignment can act like sand in the gears of the business. We provide capital that acts like a lubricant to get that machinery running smoothly again. Our capital can bridge the gap between shareholders and get everyone pulling in the same direction.”

– Scott Halsted, Managing Partner

“We’re standing on the precipice of a transformation in healthcare. I get out of bed in the morning excited to help that ecosystem thrive and to hopefully accelerate the path forward for humankind.”

– Keegan Hasson, Senior Associate

“We don’t just provide growth capital. We solve complex issues which allow companies and investors to maximize value for key stakeholders.”

– Fred Lee, Partner

“We have an affordability and access problem in our healthcare system. I’m excited to support innovative healthcare companies and their investors to meaningfully improve the healthcare system.”

– Rob Rein, Vice President

“My focus is on providing liquidity to companies and their shareholders who are leading the next generation of innovative therapeutic and diagnostic modalities that will revolutionize patient care.”

– Doug Fisher, Partner

“Investors believe they have two doors to exit, IPO and M&A. When those doors are locked or too far away in time, we offer a third door. What is great about our door is it comes in all shapes and sizes. We build customized doors to fit the needs of shareholders that desire an exit. Meeting shareholder needs is how we have built our business.”

– Mike Boggs, Managing Partner

“The healthcare industry has a profound impact on our lives, but it faces significant challenges. I believe we do more than facilitate growth – we solve problems that help nudge the industry down a path of continued improvement.”

– Garrett Brown, Senior Associate